Applied Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
17 Jun 2025	Form 3: Bailey Evan Prescott, Chief Medical Officer Holds 541,669 shares of Common Stock
20 Dec 2024	Form 3: Johnson John, Director No securities owned
15 Apr 2024	Form 3: Hooks Corwin Dale, Chief Commercial Officer No securities owned
18 Mar 2024	Form 3: Chinoporos Constantine, See Remarks No securities owned
23 Jun 2023	Form 3: Thorpe Catherine, Chief Accounting Officer No securities owned
18 Mar 2022	Form 3: Ortega Steven A., Principal Accounting Officer Holds 12,323 shares of Common Stock
26 May 2020	Form 3: Silberstein Charles, Chief Financial Officer Holds 0 shares of No securities beneficiallly owned
03 Apr 2020	Form 3: Mahadevan Chids, Chief Accounting Officer Holds 25 shares of Common Stock
05 Mar 2020	Form 3: Hansard Adam, Chief Commercial Officer Holds 0 shares of No securities beneficially owned
13 May 2019	Form 3: Alexandria Real Estate Equities Inc, 10% owner and 1 other
13 May 2019	Form 3: Vignola Mark J., Chief Financial Officer
13 May 2019	Form 3: Skyler Jay S, Director No securities owned
13 May 2019	Form 3: Shendelman Shoshana, Director Holds 3,480,662 shares of Common Stock
13 May 2019	Form 3: Perfetti Riccardo, Chief Medical Officer
13 May 2019	Form 3: Marcus Joel S, Director Holds 9,171 shares of Common Stock
13 May 2019	Form 3: Lerner Teena, Director Holds 9,171 shares of Common Stock
13 May 2019	Form 3: Kanter Stacy J., Director No securities owned
13 May 2019	Form 3: Funtleyder Leslie D., Director Holds 9,171 shares of Common Stock

Comments